atezolizumab bevacizumab fda approval

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
atezolizumab bevacizumab fda approval	1.47	0.8	1811	32	37
atezolizumab	0.19	0.8	3270	37	12
bevacizumab	1.62	0.7	8798	38	11
fda	1.82	0.6	2727	45	3
approval	0.09	0.1	8401	46	8

Keyword	CPC	PCC	Volume	Score
atezolizumab bevacizumab fda approval	1.88	0.4	4757	84
atezolizumab fda approval history	0.03	0.2	3699	45
atezolizumab fda approval date	0.32	0.4	1016	10
is atezolizumab fda approved	0.52	0.1	387	18
atezolizumab in combination with bevacizumab	0.42	0.3	8643	64
atezolizumab and bevacizumab cost	1.75	0.9	6874	52
atezolizumab fda approval breast cancer	0.41	0.2	4925	15
adjuvant atezolizumab fda approval	1.39	0.2	5382	68
atezolizumab + bevacizumab	1.91	0.7	4135	34
atezolizumab fda approval nsclc	1.79	0.3	3673	30
atezolizumab fda approval lung cancer	0.38	0.4	2948	45
atezolizumab and bevacizumab for liver cancer	1.84	0.8	5303	47
atezolizumab and bevacizumab protocol	1.36	0.9	74	40
atezolizumab breast cancer fda	0.07	0.2	4336	12
bevacizumab fda approval history	1.66	0.2	5011	19
atezolizumab and fda indications	1.65	0.5	3895	25
atezolizumab and bevacizumab hcc	0.18	0.5	4301	5
atezolizumab adjuvant nsclc fda	0.57	0.3	1605	17
atezolizumab price in usa	0.97	0.4	1005	88
atezolizumab+bev	0.48	0.3	4689	22